Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Non-Current Assets (2022 - 2025)

Mangoceuticals' Other Non-Current Assets history spans 4 years, with the latest figure at $16942.0 for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $16942.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $16942.0, a 0.0% change, with the full-year FY2024 number at $16942.0, changed 0.0% from a year prior.
  • Other Non-Current Assets hit $16942.0 in Q3 2025 for Mangoceuticals, roughly flat from $16942.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for MGRX hit a ceiling of $150375.0 in Q3 2023 and a floor of $16942.0 in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $36794.1 across 4 years, with a median of $16942.0 in 2022.
  • The widest YoY moves for Other Non-Current Assets: up 618.53% in 2024, down 88.73% in 2024.
  • Tracing MGRX's Other Non-Current Assets over 4 years: stood at $16942.0 in 2022, then changed by 0.0% to $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then changed by 0.0% to $16942.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for MGRX at $16942.0 in Q3 2025, $16942.0 in Q2 2025, and $16942.0 in Q1 2025.